Phenotypic changes of Epo‐producing cells have previously been observed, which led to the suggestion that loss of Epo expression and development of renal anaemia during CKD may at least partially be a consequence of transdifferentiation of Epo‐producing cells into myofibroblasts.34, 35. This evidence concerns the gene EPO and chronic kidney disease.